Genomic Pathway Of Gut Microbiome To Predict Efficacy Of Nivolumab In Advanced Gastric Cancer: Deliver Trial (Jaccro Gc-08)
JOURNAL OF CLINICAL ONCOLOGY（2021）
摘要
161Background: Nivolumab (Nivo) monotherapy demonstrated survival benefit in previously treated gastric cancer (GC) patients (pts) (Kang YK, et al. Lancet 2017). About 60% of the pts did not respon...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要